Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients

NCT07591480 | Not Yet Recruiting DMC

• 2 other identifiers: 2026-0019NCI-2026-02708
• Study Type: observational
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this research is to understand why some groups of people do not join clinical trials as much as others. These groups can include people from different racial or ethnic backgrounds, people with lower incomes, people who live in rural areas, and people who speak different languages. Investigators interview participants to learn about their experiences with clinical trials. By learning from them, investigators hope to find better ways to help more people learn about, join, and stay in clinical trials so that research is fair and helpful for everyone.

Conditions

Pancreatic Cancer

Outcome Measures

Primary Outcomes (1)

• Questionnaires/Surveys

  Identification of specific opportunities for improvement to increase study enrollment.

  Through study completion; an average of 1 year

Study Arms (1)

All patients

Participants will be sampled using pre-selected demographic, geographic, and clinical characteristics, allowing for purposive sampling among patients with characteristics where disparities are known to exist.

Other: Interviews

Interventions

Interviews OTHER

Participants will be offered a 30 to 45-minute telephone or video in-depth interview at a specific time convenient to the participants.

All patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

UT MD Anderson

You may qualify if:

• In order to be eligible to participate in this study, an individual must meet all of the following criteria:
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Males and females; Age ≥18
• Documented diagnosis of pancreatic cancer
• Access to necessary resources for participating in a technology-based intervention (i.e., computer, smartphone, internet access)

You may not qualify if:

• An individual who meets any of the following criteria will be excluded from participation in this study:
• Patients who speak a primary language other than English or Spanish
• Patients who are cognitively impaired
• Pregnant women

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

UT MD Anderson

Houston, Texas, 77030, United States

Location

Related Links

• UT MD Anderson Website

MeSH Terms

Conditions

Pancreatic Neoplasms

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Endocrine Gland Neoplasms; Digestive System Diseases; Pancreatic Diseases; Endocrine System Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Rebecca A Snyder, MD, MPH

  UT MD Anderson

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Rebecca A Snyder, MD, MPH

CONTACT

(713) 792-0036; rsnyder@mdanderson.org

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 8, 2026
• First Posted: May 15, 2026
• Study Start: May 1, 2026
• Primary Completion (Estimated): October 1, 2026
• Study Completion (Estimated): October 1, 2028
• Last Updated: May 15, 2026

Record last verified: 2026-05

Locations

US (1)